Enviar búsqueda
Cargar
Regulatory affairs
•
Descargar como PPT, PDF
•
44 recomendaciones
•
19,063 vistas
S
sekhara
Seguir
Tecnología
Empresariales
Denunciar
Compartir
Denunciar
Compartir
1 de 10
Descargar ahora
Recomendados
It constitutes of basic introduction of regulatory affairs in pharmaceuticals, career in pharma regulatory affairs, job opportunities and future aspect. GIBTIndia offers job oriented e- learning courses. Kindly visit us at www.gibtindia.com
Introduction to Pharma regulatory affairs
Introduction to Pharma regulatory affairs
GIBT India
Drug Regulatory Affairs Introduction
Drug Regulatory Affairs
Drug Regulatory Affairs
Namdeo Shinde
Introduction, Historical overview of regulatory affairs, Regulatory authorities, Role of regulatory affair department, Responsibility
Regulatory affairs
Regulatory affairs
SandhyaPunetha1
Regulatory Affairs.
Regulatory Affairs.
Naila Kanwal
central drug standard control organisation CDSCO and sate licensing authority of India, organisation and their responsibilities
Pharmaceutical Licecnsing authorites of india
Pharmaceutical Licecnsing authorites of india
Atul Bhombe
Hi, everyone i am providing you the best presentation about the Pakistan relate Drug regulatory affairs and the concept of regulatory affairs of Pharmaceuticals
Regulatory affairs by Aneela Saleem
Regulatory affairs by Aneela Saleem
AneelaSaleem
Short discussion about Regulatory affairs (RA) by Dipak Bhingardeve
Regulatory affairs
Regulatory affairs
Dipak Bhingardeve
CDSCO, State FDA, DCGI
Drug regulatory authority
Drug regulatory authority
Rahul Gawande
Recomendados
It constitutes of basic introduction of regulatory affairs in pharmaceuticals, career in pharma regulatory affairs, job opportunities and future aspect. GIBTIndia offers job oriented e- learning courses. Kindly visit us at www.gibtindia.com
Introduction to Pharma regulatory affairs
Introduction to Pharma regulatory affairs
GIBT India
Drug Regulatory Affairs Introduction
Drug Regulatory Affairs
Drug Regulatory Affairs
Namdeo Shinde
Introduction, Historical overview of regulatory affairs, Regulatory authorities, Role of regulatory affair department, Responsibility
Regulatory affairs
Regulatory affairs
SandhyaPunetha1
Regulatory Affairs.
Regulatory Affairs.
Naila Kanwal
central drug standard control organisation CDSCO and sate licensing authority of India, organisation and their responsibilities
Pharmaceutical Licecnsing authorites of india
Pharmaceutical Licecnsing authorites of india
Atul Bhombe
Hi, everyone i am providing you the best presentation about the Pakistan relate Drug regulatory affairs and the concept of regulatory affairs of Pharmaceuticals
Regulatory affairs by Aneela Saleem
Regulatory affairs by Aneela Saleem
AneelaSaleem
Short discussion about Regulatory affairs (RA) by Dipak Bhingardeve
Regulatory affairs
Regulatory affairs
Dipak Bhingardeve
CDSCO, State FDA, DCGI
Drug regulatory authority
Drug regulatory authority
Rahul Gawande
Regulatory affairs is a profession developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines.
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical Industry
Rama Shukla
A brief introduction to Drug Regulatory Affairs and Its Regulatory Authority.
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
Siddharth Kumar Sahu
ACTD Guidelines Overview
ACTD Guidelines Overview
Muhammad Ali Jehangir
The presentation is about: Drug Regulatory Affairs as a profession, Scope & Responsibilities in life cycle management of a drug and role of RA in the drug approval process.
Regulatory Affairs Profession
Regulatory Affairs Profession
Institute of Pharmaceutical Management
Regulatory Affairs
Regulatory Affairs
ShabeenaZaidi
drug regulatory affaris
Drug regulatory affairs - 1
Drug regulatory affairs - 1
Tanuja Bisht
CENTRAL DRUG STANDARD CONTROL ORGANISATION (CDSCO)
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
R.C patel institute of pharmacutical education and research, shirpur
The NDA application is the vehicle through which drug sponsors, such as biotech and pharmaceutical companies, formally propose that the FDA approve a new pharmaceutical for sale and marketing
New Drug Application [NDA]
New Drug Application [NDA]
Sagar Savale
This presentation covers basic understandings of regulatory affairs profession. It contains, 1. Introduction of Regulatory Affairs 2. Why Drug Regulatory Affairs 3. Role of Regulatory Affairs Experts 4. Qualities of Regulatory Affairs Expert 5. Qualities for Submission Management 6. Regulatory Bodies
Drug Regulatory Affairs By Mr. Pankaj Dhapade
Drug Regulatory Affairs By Mr. Pankaj Dhapade
Pankaj Dhapade
a regulatory body of India that conducted trial.
Cdsco ppt
Cdsco ppt
Nikhat Sheikh
Certificate of Pharmaceutical Product
COPP.pptx
COPP.pptx
Venugopal N
Schedule Y amended version 2005, I hope this is useful to All Clinical Research Professionals. -Thank You
Schedule Y
Schedule Y
kamalakar ambati
This includes the following contents: 1. Introduction 2. Procedure for Export of products 3. Technical Documentations MFR, BMR, COA, COPP 4. Drug Master File 5. Common Technical Document 6. Electronic Common Technical Documents 7. ASEAN Common Technical Document
Registration of Indian Drug Product in Overseas Market.pptx
Registration of Indian Drug Product in Overseas Market.pptx
Nipun Gupta
Central drug standard control organisation
Central drug standard control organisation
bdvfgbdhg
Electronic Common Technical Documents
eCTD
eCTD
Cyclone Pharmaceutical Pvt Ltd
DMF is Drug master file which comprises the CMC part(i.e. Chemistry Manufacturing and Critical Control) of the drug substance
DMF -Drug Master File
DMF -Drug Master File
Cyclone Pharmaceutical Pvt Ltd
Regulatory guidelines of Australia
Regulatory guidelines of Australia
nandiniwarier93
ASEAN COMMON TECHNICAL DOSSIER
ACTD- ASEAN
ACTD- ASEAN
Naila Kanwal
5. Unit-V- Regulatory Concepts. B. Pharm. Final Year, Sem-VIII, BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory), As PCI Syllabus.
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
Audumbar Mali
OVERVIEW OF ICH GUIDELINES
ICH GUIDELINES
ICH GUIDELINES
Naveen Kumar
regulatory authority
Regulatory authorities of copyright liasion
Regulatory authorities of copyright liasion
RAMZAHASHMI
REGULATORY AFFAIRS
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
JAYACHANDRA AKUTHOTA
Más contenido relacionado
La actualidad más candente
Regulatory affairs is a profession developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines.
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical Industry
Rama Shukla
A brief introduction to Drug Regulatory Affairs and Its Regulatory Authority.
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
Siddharth Kumar Sahu
ACTD Guidelines Overview
ACTD Guidelines Overview
Muhammad Ali Jehangir
The presentation is about: Drug Regulatory Affairs as a profession, Scope & Responsibilities in life cycle management of a drug and role of RA in the drug approval process.
Regulatory Affairs Profession
Regulatory Affairs Profession
Institute of Pharmaceutical Management
Regulatory Affairs
Regulatory Affairs
ShabeenaZaidi
drug regulatory affaris
Drug regulatory affairs - 1
Drug regulatory affairs - 1
Tanuja Bisht
CENTRAL DRUG STANDARD CONTROL ORGANISATION (CDSCO)
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
R.C patel institute of pharmacutical education and research, shirpur
The NDA application is the vehicle through which drug sponsors, such as biotech and pharmaceutical companies, formally propose that the FDA approve a new pharmaceutical for sale and marketing
New Drug Application [NDA]
New Drug Application [NDA]
Sagar Savale
This presentation covers basic understandings of regulatory affairs profession. It contains, 1. Introduction of Regulatory Affairs 2. Why Drug Regulatory Affairs 3. Role of Regulatory Affairs Experts 4. Qualities of Regulatory Affairs Expert 5. Qualities for Submission Management 6. Regulatory Bodies
Drug Regulatory Affairs By Mr. Pankaj Dhapade
Drug Regulatory Affairs By Mr. Pankaj Dhapade
Pankaj Dhapade
a regulatory body of India that conducted trial.
Cdsco ppt
Cdsco ppt
Nikhat Sheikh
Certificate of Pharmaceutical Product
COPP.pptx
COPP.pptx
Venugopal N
Schedule Y amended version 2005, I hope this is useful to All Clinical Research Professionals. -Thank You
Schedule Y
Schedule Y
kamalakar ambati
This includes the following contents: 1. Introduction 2. Procedure for Export of products 3. Technical Documentations MFR, BMR, COA, COPP 4. Drug Master File 5. Common Technical Document 6. Electronic Common Technical Documents 7. ASEAN Common Technical Document
Registration of Indian Drug Product in Overseas Market.pptx
Registration of Indian Drug Product in Overseas Market.pptx
Nipun Gupta
Central drug standard control organisation
Central drug standard control organisation
bdvfgbdhg
Electronic Common Technical Documents
eCTD
eCTD
Cyclone Pharmaceutical Pvt Ltd
DMF is Drug master file which comprises the CMC part(i.e. Chemistry Manufacturing and Critical Control) of the drug substance
DMF -Drug Master File
DMF -Drug Master File
Cyclone Pharmaceutical Pvt Ltd
Regulatory guidelines of Australia
Regulatory guidelines of Australia
nandiniwarier93
ASEAN COMMON TECHNICAL DOSSIER
ACTD- ASEAN
ACTD- ASEAN
Naila Kanwal
5. Unit-V- Regulatory Concepts. B. Pharm. Final Year, Sem-VIII, BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory), As PCI Syllabus.
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
Audumbar Mali
OVERVIEW OF ICH GUIDELINES
ICH GUIDELINES
ICH GUIDELINES
Naveen Kumar
La actualidad más candente
(20)
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical Industry
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
ACTD Guidelines Overview
ACTD Guidelines Overview
Regulatory Affairs Profession
Regulatory Affairs Profession
Regulatory Affairs
Regulatory Affairs
Drug regulatory affairs - 1
Drug regulatory affairs - 1
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
New Drug Application [NDA]
New Drug Application [NDA]
Drug Regulatory Affairs By Mr. Pankaj Dhapade
Drug Regulatory Affairs By Mr. Pankaj Dhapade
Cdsco ppt
Cdsco ppt
COPP.pptx
COPP.pptx
Schedule Y
Schedule Y
Registration of Indian Drug Product in Overseas Market.pptx
Registration of Indian Drug Product in Overseas Market.pptx
Central drug standard control organisation
Central drug standard control organisation
eCTD
eCTD
DMF -Drug Master File
DMF -Drug Master File
Regulatory guidelines of Australia
Regulatory guidelines of Australia
ACTD- ASEAN
ACTD- ASEAN
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
ICH GUIDELINES
ICH GUIDELINES
Similar a Regulatory affairs
regulatory authority
Regulatory authorities of copyright liasion
Regulatory authorities of copyright liasion
RAMZAHASHMI
REGULATORY AFFAIRS
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
JAYACHANDRA AKUTHOTA
What are regulatory bodies:- In the present scenario, pharmaceuticals are considered as the most highly regulated industries worldwide. The regulatory body ensures compliances in various legal and regulatory aspects of a drug. Every country has its own regulatory authority, which is responsible to enforce the rules and regulations and issue the guidelines to regulate drug development process, licensing, registration, manufacturing. marketing and labeling of pharmaceutical products like: USFDA(USA) MHRA(UK) TGA(Australia AIMS:- Protecting public health through regulation, with acceptablebenefit-risk profiles for medicines and devices. Promoting public health by helping people who use these productsto understand their benefits and risks. Improving public health by encouraging and facilitating developments in products that will benefit people GUIDELINES:- Guidelines for Manufacturers on Clinical Investigations to be carried out in the UK. Inspected UK Contract GMP Quality Control Laboratories. BLUE GUIDE: Advertising and Promotion of medicines in the UK. ORANGE GUIDE: Rules and Guidelines for Pharmaceutical Manufacturers and Distributors. Good Pharmacovigilance Practice Guide. Guidelines on Process Validation Guide to UK GLP Regulations 1999 Recommendations on the control and monitoring of storage and transportation temperatures of medicinal products. Guide to defective medicinal products. Introduction of a Risk Based Inspection Programme for GMP Labs. SALIENT FEATURES, COMMITTEES/WORKING GROUPS:- MHRA has the power to withdraw a product from market and suspend production of medicines. A manufacturer or distributor can be prosecuted if the law has been broken. Regulatory decisions are impartial D Different products are treated differently. MHRA collaborates with : US Food and Drug Administration NPSA National Patient Safety Agency NICE National Institute for Health and Clinical Excellence
Medicines and Healthcare products Regulatory Agency(MHRA)
Medicines and Healthcare products Regulatory Agency(MHRA)
TMU
for mpharm
Cdsco Roles and Responsibilities
Cdsco Roles and Responsibilities
Sandip Mavchi
Drug Regulatory Affairs
Regulatory affairs by sachin gundecha
Regulatory affairs by sachin gundecha
Sachin Gundecha
Industrial Pharmacy - II, Unit - III
REGULATORY AFFAIRS.pptx
REGULATORY AFFAIRS.pptx
Chaitali Dongaonkar
Reach me brilliantvikram@gmail.com
Pharma Regulatory & licensing Service
Pharma Regulatory & licensing Service
Vikram sathish Asokan
Strategy for enhanced marketing authorization final docx
Strategy for enhanced marketing authorization final docx
Fasika Alemu
Drug Regulatory Affairs refers to all aspects within the pharmaceutical development process and how they are subject to various degrees of regulation.
Drug Regulatory Affairs
Drug Regulatory Affairs
Ashwani Dhingra
Marketing Authorization procedures in developed and developing countries
Marketing Authorization procedures in developed and developing countries
Akshay Saxena
Ra profession diff ra bodies indian pharma scenario_31st oct-2010 - copy
Ra profession diff ra bodies indian pharma scenario_31st oct-2010 - copy
Raaj Global Pharma Regulatory Affiairs
Quality regulation for biological products current and future
Quality regulation for biological products current and future
National Institute of Biologics
this ppt is about all the rules and regulations of drugs in Japan.this ppt contains the PMDA structure, DMF data, IND and NDA procedure, cosmetic regulations, post marketing survelliance etc.
Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan ppt
sandeep bansal
This presentation will give an idea about different Regulatory bodies and their Objectives to protect public health. Rules and Regulations
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Rajashri Survase Ojha
To import Drug into India, the Site of manufacturing & products are to be registered.We give Services in getting manufacturing licences ACCREDITED CONSULTANTS PVT.LTD info@acplgroupindia.co.in +919310040434
Drug registration
Drug registration
Prasad Bhat
Responsibilities and Functions of CDSCO
CDSCO.pptx
CDSCO.pptx
mamtakumari930473
A brief introductory presentation about National Drug Regulatory Authority of India for Indian Pharmaceuticals and Medical Devices i.e. CDSCO. By Pratibha Chaudhary, pursuing Mpharm DRA from Amity University.
CDSCO - Central Licensing Authority
CDSCO - Central Licensing Authority
PratibhaChaudhary16
COMMON REGULATORY AFFAIRS JOB INTERVIEW QUESTIONS WITH ANSWERS By Pristyn Research-Updated 2022. A quick Job interview short guide For Pharma and all Life science jobseekers. info.pristynresearch.com www.pristynresearch.com 9028839789 | 8999717656 All Medical | Biotech |Micro |B.Sc., M.Sc. PAN India DRA companies list alphabetically
COMMON REGULATORY AFFAIRS JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated in 2022!
COMMON REGULATORY AFFAIRS JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated in 2022!
Pristyn Research Solutions
It includes information about regulatory bodies, role of drug Regulatory professional, countries with their regulatory bodies, intellectual property rights, terminologies related to DRA, drug approval process, event regarding lack of Drug regulatory affairs
DRUG REGULATORY AFFAIRS
DRUG REGULATORY AFFAIRS
RujutaNamdevbhor
B. Pharm. Final Year, Sem:- VII, INDUSTRIAL PHARMACY-II, Unit 3 chapter 3 regulatory affairs, As per PCI Syllabus
regulatory affairs ip ii final
regulatory affairs ip ii final
Audumbar Mali
Similar a Regulatory affairs
(20)
Regulatory authorities of copyright liasion
Regulatory authorities of copyright liasion
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
Medicines and Healthcare products Regulatory Agency(MHRA)
Medicines and Healthcare products Regulatory Agency(MHRA)
Cdsco Roles and Responsibilities
Cdsco Roles and Responsibilities
Regulatory affairs by sachin gundecha
Regulatory affairs by sachin gundecha
REGULATORY AFFAIRS.pptx
REGULATORY AFFAIRS.pptx
Pharma Regulatory & licensing Service
Pharma Regulatory & licensing Service
Strategy for enhanced marketing authorization final docx
Strategy for enhanced marketing authorization final docx
Drug Regulatory Affairs
Drug Regulatory Affairs
Marketing Authorization procedures in developed and developing countries
Marketing Authorization procedures in developed and developing countries
Ra profession diff ra bodies indian pharma scenario_31st oct-2010 - copy
Ra profession diff ra bodies indian pharma scenario_31st oct-2010 - copy
Quality regulation for biological products current and future
Quality regulation for biological products current and future
Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan ppt
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Drug registration
Drug registration
CDSCO.pptx
CDSCO.pptx
CDSCO - Central Licensing Authority
CDSCO - Central Licensing Authority
COMMON REGULATORY AFFAIRS JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated in 2022!
COMMON REGULATORY AFFAIRS JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated in 2022!
DRUG REGULATORY AFFAIRS
DRUG REGULATORY AFFAIRS
regulatory affairs ip ii final
regulatory affairs ip ii final
Último
Effective data discovery is crucial for maintaining compliance and mitigating risks in today's rapidly evolving privacy landscape. However, traditional manual approaches often struggle to keep pace with the growing volume and complexity of data. Join us for an insightful webinar where industry leaders from TrustArc and Privya will share their expertise on leveraging AI-powered solutions to revolutionize data discovery. You'll learn how to: - Effortlessly maintain a comprehensive, up-to-date data inventory - Harness code scanning insights to gain complete visibility into data flows leveraging the advantages of code scanning over DB scanning - Simplify compliance by leveraging Privya's integration with TrustArc - Implement proven strategies to mitigate third-party risks Our panel of experts will discuss real-world case studies and share practical strategies for overcoming common data discovery challenges. They'll also explore the latest trends and innovations in AI-driven data management, and how these technologies can help organizations stay ahead of the curve in an ever-changing privacy landscape.
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc
Accelerating FinTech Innovation: Unleashing API Economy and GenAI Vasa Krishnan, Chief Technology Officer - FinResults Apidays New York 2024: The API Economy in the AI Era (April 30 & May 1, 2024) ------ Check out our conferences at https://www.apidays.global/ Do you want to sponsor or talk at one of our conferences? https://apidays.typeform.com/to/ILJeAaV8 Learn more on APIscene, the global media made by the community for the community: https://www.apiscene.io Explore the API ecosystem with the API Landscape: https://apilandscape.apiscene.io/
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
apidays
Angeliki Cooney has spent over twenty years at the forefront of the life sciences industry, working out of Wynantskill, NY. She is highly regarded for her dedication to advancing the development and accessibility of innovative treatments for chronic diseases, rare disorders, and cancer. Her professional journey has centered on strategic consulting for biopharmaceutical companies, facilitating digital transformation, enhancing omnichannel engagement, and refining strategic commercial practices. Angeliki's innovative contributions include pioneering several software-as-a-service (SaaS) products for the life sciences sector, earning her three patents. As the Senior Vice President of Life Sciences at Avenga, Angeliki orchestrated the firm's strategic entry into the U.S. market. Avenga, a renowned digital engineering and consulting firm, partners with significant entities in the pharmaceutical and biotechnology fields. Her leadership was instrumental in expanding Avenga's client base and establishing its presence in the competitive U.S. market.
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Angeliki Cooney
The CNIC Information System is a comprehensive database managed by the National Database and Registration Authority (NADRA) of Pakistan. It serves as the primary source of identification for Pakistani citizens and residents, containing vital information such as name, date of birth, address, and biometric data.
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistan
danishmna97
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
The Digital Insurer
Corporate and higher education. Two industries that, in the past, have had a clear divide with very little crossover. The difference in goals, learning styles and objectives paved the way for differing learning technologies platforms to evolve. Now, those stark lines are blurring as both sides are discovering they have content that’s relevant to the other. Join Tammy Rutherford as she walks through the pros and cons of corporate and higher ed collaborating. And the challenges of these different technology platforms working together for a brighter future.
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
Rustici Software
The Good, the Bad and the Governed - Why is governance a dirty word? David O'Neill, Chief Operating Officer - APIContext Apidays New York 2024: The API Economy in the AI Era (April 30 & May 1, 2024) ------ Check out our conferences at https://www.apidays.global/ Do you want to sponsor or talk at one of our conferences? https://apidays.typeform.com/to/ILJeAaV8 Learn more on APIscene, the global media made by the community for the community: https://www.apiscene.io Explore the API ecosystem with the API Landscape: https://apilandscape.apiscene.io/
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
apidays
Uncertainty, Acting under uncertainty, Basic probability notation, Bayes’ Rule,
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
Khushali Kathiriya
Passkeys: Developing APIs to enable passwordless authentication Cody Salas, Sr Developer Advocate | Solutions Architect - Yubico Apidays New York 2024: The API Economy in the AI Era (April 30 & May 1, 2024) ------ Check out our conferences at https://www.apidays.global/ Do you want to sponsor or talk at one of our conferences? https://apidays.typeform.com/to/ILJeAaV8 Learn more on APIscene, the global media made by the community for the community: https://www.apiscene.io Explore the API ecosystem with the API Landscape: https://apilandscape.apiscene.io/
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
apidays
writing some innovation for development and search
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
sudhanshuwaghmare1
Following the popularity of "Cloud Revolution: Exploring the New Wave of Serverless Spatial Data," we're thrilled to announce this much-anticipated encore webinar. In this sequel, we'll dive deeper into the Cloud-Native realm by uncovering practical applications and FME support for these new formats, including COGs, COPC, FlatGeoBuf, GeoParquet, STAC, and ZARR. Building on the foundation laid by industry leaders Michelle Roby of Radiant Earth and Chris Holmes of Planet in the first webinar, this second part offers an in-depth look at the real-world application and behind-the-scenes dynamics of these cutting-edge formats. We will spotlight specific use-cases and workflows, showcasing their efficiency and relevance in practical scenarios. Discover the vast possibilities each format holds, highlighted through detailed discussions and demonstrations. Our expert speakers will dissect the key aspects and provide critical takeaways for effective use, ensuring attendees leave with a thorough understanding of how to apply these formats in their own projects. Elevate your understanding of how FME supports these cutting-edge technologies, enhancing your ability to manage, share, and analyze spatial data. Whether you're building on knowledge from our initial session or are new to the serverless spatial data landscape, this webinar is your gateway to mastering cloud-native formats in your workflows.
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
Presentation on the progress in the Domino Container community project as delivered at the Engage 2024 conference
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
Martijn de Jong
We present an architecture of embedding models, vector databases, LLMs, and narrow ML for tracking global news narratives across a variety of countries/languages/news sources. As an example, we explore the real-time application of this architecture for tracking the news narrative surrounding the death of Russian opposition leader Alexei Navalny coming from Russian, French, and English sources.
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Zilliz
When you’re building (micro)services, you have lots of framework options. Spring Boot is no doubt a popular choice. But there’s more! Take Quarkus, a framework that’s considered the rising star for Kubernetes-native Java. It always depends on what's best for your situation, but how to choose the best solution if you're comparing 2 frameworks? Both Spring Boot and Quarkus have their positives and negatives. Let us compare the two by live coding a couple of common use cases in Spring Boot and Quarkus. After this talk, you’ll be ready to get started with Quarkus yourself, and know when to select Quarkus or Spring Boot.
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Jago de Vreede
Dubai, known for its towering skyscrapers, luxurious lifestyle, and relentless pursuit of innovation, often finds itself in the global spotlight. However, amidst the glitz and glamour, the emirate faces its own set of challenges, including the occasional threat of flooding. In recent years, Dubai has experienced sporadic but significant floods, disrupting normalcy and posing unique challenges to its infrastructure. Among the critical nodes in this bustling metropolis is the Dubai International Airport, a vital hub connecting the world. This article delves into the intersection of Dubai flood events and the resilience demonstrated by the Dubai International Airport in the face of such challenges.
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Orbitshub
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
The Digital Insurer
Scaling API-first – The story of a global engineering organization Ian Reasor, Senior Computer Scientist - Adobe Radu Cotescu, Senior Computer Scientist - Adobe Apidays New York 2024: The API Economy in the AI Era (April 30 & May 1, 2024) ------ Check out our conferences at https://www.apidays.global/ Do you want to sponsor or talk at one of our conferences? https://apidays.typeform.com/to/ILJeAaV8 Learn more on APIscene, the global media made by the community for the community: https://www.apiscene.io Explore the API ecosystem with the API Landscape: https://apilandscape.apiscene.io/
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
apidays
DBX 1Q24 Investor Presentation
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
Dropbox
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving. A report by Poten & Partners as part of the Hydrogen Asia 2024 Summit in Singapore. Copyright Poten & Partners 2024.
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Edi Saputra
In the thrilling conclusion to 2023, ransomware groups had a banner year, really outdoing themselves in the "make everyone's life miserable" department. LockBit 3.0 took gold in the hacking olympics, followed by the plucky upstarts Clop and ALPHV/BlackCat. Apparently, 48% of organizations were feeling left out and decided to get in on the cyber attack action. Business services won the "most likely to get digitally mugged" award, with education and retail nipping at their heels. Hackers expanded their repertoire beyond boring old encryption to the much more exciting world of extortion. The US, UK and Canada took top honors in the "countries most likely to pay up" category. Bitcoins were the currency of choice for discerning hackers, because who doesn't love untraceable money?
Ransomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdf
Overkill Security
Último
(20)
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistan
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Ransomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdf
Regulatory affairs
1.
Drug Regulatory Affairs
The Backbone of Pharmaceutical Industry .
2.
3.
4.
5.
6.
7.
8.
9.
10.
Descargar ahora